Since their discovery in 1993 
Introduction

Since the discovery of the first microRNA (miRNA) lin-4, as a regulator of developmental timing in Caenorhabditis elegans
, it has become evident that this short non-coding RNA was only the first member of a huge gene family with potentially enormous importance in the regulation of fundamental biological processes (Fig. 1 (October 26, 2001) [2] . Barely [3] . Their importance is demonstrated by the fact that mice lacking the Dicer enzyme, which is required for the processing of the precursor miRNA into the mature form, are not viable [4] [5] [6] .
). In 2000 there were only two miRNAs known (lin-4 in C. elegans and let-7 in H. sapiens), and even the term 'microRNA' was introduced only in 2001 in a set of three articles in Science
Since the discovery of miRNAs, the number of publications about miRNAs is increasing exponentially (Fig. 2 ) and significant progress has been made in dissection of biogenesis and functions of miRNAs. To date, more than 600 individual miRNAs have been identified in the human genome, which are estimated to regulate the vast majority of protein coding RNAs (mRNAs) and each mRNA is likely to be regulated by several miRNAs simultaneously [7, 8] . In total, miRNAs my comprise 5% of all human genes making them the most abundant class of regulators. Experimental evidence suggested that most miRNAs are present at very high steady-state levels -more than 1000 molecules per cell, with some exceeding 50 ,000 molecules per cell [9] .
Although we are only at the beginning of understanding the specific roles of individual miRNAs in cellular functions, several reports have provided evidence that miRNAs act as key regulators of processes as diverse as early development [10] , proliferation, differentiation, cell fate determination, apoptosis, signal transduction and organ development [5, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . These known functions probably represent only a small part of a much bigger picture. With the continuing discovery of new miRNA functions, it is possible that miRNAs will be associated with the regulation of almost every aspect of cell physiology.
Abnormal miRNA expression may lead to the development of diseases; compelling studies have implicated miRNAs in various human diseases such as cancer [17, 18, [21] [22] [23] [24] , developmental abnormalities [5] , muscular [25, 26] and cardiovascular disorders [27, 28] , schizophrenia [29] and most recently inflammatory diseases [30] [31] [32] .
In this review, we aim to summarize about our knowledge about miRNAs related to inflammatory and immunemediated diseases. Since the role of miRNAs in the normal immune system (i.e. development of immune cells and regulation of innate and acquired immune responses) have been extensively discussed elsewhere [31-36], in this review we will not discuss it in detail, but focus on what is currently known about the role of miRNAs in the pathogenesis of immune-related diseases such as chronic inflammatory skin diseases, autoimmunity and viral infections.
The biogenesis of miRNAs
Similar to ordinary protein-coding RNAs, miRNAs are encoded in the genomic DNA. To date, more than 600 miRNAs have been identified in the human genome and computational predictions suggest that there are more than 1000 miRNA genes in the human genome [37] . Approximately half of all human miRNA genes are contained within the introns of protein-coding genes or in the exons of untranslated genes, while others reside apart from known genes in intergenic regions [38] . Some miRNA primary transcripts encode only a single mature miRNA (e.g.: mir-203), while other loci contain clusters of miRNAs that appear to be produced from a single primary transcript (mir-17-92 cluster) [39] .
The generation of functional single-stranded miRNAs from miRNA genes occurs through a multi-step process that involves several different enzymes first in the cell nucleus and finally in the cytoplasm (Fig. 3) transcripts, the primary transcripts (pri-miRNAs) are capped and polyadenylated (Fig. 3) .
Pri-miRNAs contain a local stem-loop structure that encodes miRNA sequences in the arm of the stem. This stem-loop structure is cleaved in the nucleus by the dsRNA-specific ribonuclease Drosha in a process known as 'cropping' [41, 42] to release the precursor miRNA (pre-miRNA) [43] (Fig. 3) [43, 44] . The pre-miRNAs are then actively transported from the nucleus to the cytoplasm via a mechanism that involves exportin-5 (Exp5). Exp5 has been shown to bind directly and specifically to correctly processed pre-miRNAs [44, 45] .
Pre-miRNAs are subsequently cleaved by the cytoplasmic RNase III Dicer into ~22-nt miRNA duplexes [43, 44] (Fig. 3) . One strand of the short-lived miRNA duplex is degraded (miRNA* or 'passenger' strand), whereas the other strand (miR or 'guide') will be incorporated into the RISC and serve as a functional, mature miRNA (Fig. 3) . Selection of the active strand from the dsRNA appears to be based primarily on the stability of the termini of the two ends of the dsRNA [46, 47] . The strand with lower stability base pairing of the 2-4 nt at the 5Ј and 3Ј end of the duplex preferentially associates with RISC and thus becomes the functionally active miRNA [46] . The potential function -if any -of the miRNA* strand of the miRNA duplex is unclear at present (Fig. 3) . After the mature, single-stranded miRNA is selectively loaded into the RISC, this miRNA-programmed RISC (miRISC) carries out the repression of gene expression (Fig. 3) .
Interestingly, the complex containing active miRNAs and the RISC involved in RNA interference mediated by siRNAs are similar if not identical, as endogenous miRNAs can cleave mRNAs with perfect complementarity [48] , and exogenously introduced siRNAs can translationally repress mRNAs bearing imperfectly complementary binding sites [49] [50] [51] .
Mechanism of action of miRNAs
MiRNAs bind to complementary sequences in the 3ЈUTR of target mRNA (s) and can prevent protein synthesis by two modes of action: (1) in cases where the miRNA is only partially complementary to its corresponding mRNA, translation inhibition occurs [7] and (2) degradation of the target mRNA occurs [52, 53] [59] .
Each miRNA is thought to regulate multiple genes, and since hundreds of miRNA genes are predicted to be present in higher eukaryotes [20, 60, 61] [7] . Thus, predicted miRNA : mRNA interactions must be viewed in the context of other potential interactions. [7] . The 3Ј region of the miRNA can modulate activity in certain circumstances but is considered to be less critical [7] . (5) positioning away from the centre of long UTRs [63] .
Identification of miRNA targets
In addition to providing insights and constraints for mechanistic models, these context features provide valuable information for the researcher who is facing the difficult task of trying to select the most promising miRNA-target genes for experimental follow-up [63] (http://www.targetscan.org).
Despite [65] .
Most miRNA genes that are located in intergenic regions are also transcribed by RNA polymerase II [42, 66, 67] [68] . For many miRNAs, the level of the mature miRNA in the cell is not simply determined by the level of transcription. Comparison of tumour-specific mature miRNA expression with pri-miRNA transcript levels showed poor correlation indicating that also the maturation of the pri-miRNA transcript is a regulated process [64] .
In addition to regulation at the transcriptional and posttranscriptional levels, several independent studies have shown that epigenetic mechanisms also affect the expression of miRNA genes [69] [70] [71] [72] [36, 78] [85] . Transgenic mice overexpressing miR-203 are characterized by thinner epidermis and impaired proliferative potential (repression of 'stemness') [85] , whereas psoriasis is characterized by epidermal hyperproliferation. These seemingly conflicting findings may reflect the dysfunction of miR-203 in psoriatic patients, for example by mutations that affect some of its target genes. 
. Of note, miR-125b has been implicated in the negative regulation of the TNF-␣ pathway [78], which is of crucial importance in the development of psoriasis, as demonstrated by the effectiveness of anti-TNF-␣ therapies [68]. Further studies are in progress to identify the specific roles of these miRNAs in the altered immune responses in psoriasis and atopic eczema. In addition to miRNAs previously implicated in immune functions, the study identified several inflammation-associated miRNAs whose function and expression was unknown, such as miR-203. MiR-203 showed a strikingly specific expression pattern, being expressed exclusively in skin and oesophagus, and within cells types of the skin, exclusively in keratinocytes [30]. The authors identified suppressor of cytokine signalling-3 (SOCS-3) as a potential target of miR-203, showing mutually exclusive expression pattern with miR-203 and showing suppressed expression in psoriasis lesional skin compared with healthy skin. SOCS-3 is a negative regulator of the interleukin (IL)-6 and interferon (IFN)-␥ induced signalling pathways [30] and SOCS-3 deficiency leads to sustained activation of STAT3 in response to IL-6 [83]. Therefore, the suppression of SOCS-3 by miR-203 may result in an increased or elongated inflammatory response in the skin. Direct regulation of SOCS-3 by miR-203 was also confirmed using luciferase 3ЈUTR assays (unpublished data). In a recent study, SOCS-3 protein levels were not suppressed in primary mouse keratinocytes overexpressing miR-203 [84]; this may reflect a difference between human and mouse, although it is more likely that detection of SOCS3 by Western blotting is less reliable due to the low level of SOCS-3 expression in unstimulated cells. Suppression of SOCS-3 by miR-203 may lead to sustained STAT-3 activation and an increased and elongated inflammatory response in the skin. Interestingly, the murine orthologue of miR-203 has been demonstrated to play an important role in epidermal morphogenesis
In conclusion, miRNAs deregulated in psoriasis and atopic eczema have the potential to become targets for future therapeutic interventions to treat chronic skin inflammatory diseases, and potentially even inflammatory diseases affecting other organs.
Asthma
Recently, an indirect evidence for the potential involvement of miRNAs in asthma appeared, in a report describing that an SNP in the 3ЈUTR of HLA-G, a known asthma-susceptibility gene, disrupts the binding sites of three miRNAs (miR-148a, miR-148b and miR-152) targeting this gene [81]. Although direct evidence is missing, it is likely that earlier observations on the association of the HLA-G gene to asthma susceptibility
Systemic lupus erythematosus
The first indication that miRNA deregulation might play a role in autoimmunity was a report by Dai et al. in 2007 [88] [89] .
Primary biliary cirrhosis
A very recent study implicated miRNAs in primary biliary cirrhosis (PBC), an autoimmune disease characterized by lymphocytic infiltrates in the portal tracts and anti-mitochondrial antibodies
Comparison of miRNA expression profiles using oligonucleotide arrays in peripheral blood cells of PBC patients and healthy controls revealed down-regulation of 23 miRNAs (e.g. let-7b, miR-17-5p, miR-346 and miR-20a) and up-regulation of 2 miRNAs (miR-451 and miR-129). The functional significance of the miRNA deregulation in PBC was demonstrated by transfection of anti-let-7b, antimiR-346, anti-miR-17-5p (inhibition of miRNAs) and pre-miR-129 (overexpression of miRNAs) into autoantigen-specific T cells. The transfected cells showed a significant increase in proliferation and IFN-␥ production. Hence, aberrant expression of these miRNAs may contribute to autoimmunity by affecting the proliferation and activation of autoreactive immune cells. Overexpression of miR-17-5p in PDC-E2-specific T cells led to decreased protein (but not mRNA) expression of one of its predicted targets, TNFRSF21 (death receptor 6 (DR6)), while inhibition of miR-17-5p increased TNFRSF21
expression, suggesting that miR-17-5p might target TNFRSF21 for translational repression. In the same setting, the authors showed that let-7d might target IL-6. However, it has not been confirmed whether these genes are targeted directly by miR-17-5p and let-7d.
miR-17-5p and miR-101 in autoimmunity
Interestingly, down-regulation of miR-17-5p was observed in peripheral blood cells from patients with SLE, ITP and PBC, three autoimmune diseases targeting different organs, pointing to an important role of this miRNA in human autoimmune disorders [88, 89] . miR -17- 
Another recent report using a mouse model for autoimmunity revealed a novel pathway that prevents autoimmunity by limiting the levels of a co-stimulatory receptor, the inducible T-cell stimulator (ICOS) on T lymphocytes, [91]. The novel pathway involves the gene called Roquin, which can undergo a specific mutation (M199R) that results in instructing T cells to react against the self, as previously shown by the same group in 2005 [92]. The sanroque mice homozygous for the M199R mutation develop a lupuslike autoimmune syndrome, with lymphadenopathy, splenomegaly and accumulation of T cells. In their new study, the authors show that in these mice, ICOS overexpression is an essential contributor to the phenotype, indicating that tight regulation of ICOS by Roquin is critical to prevent T-and B-cell accumulation [91]. The authors demonstrate that binding of miR-101 (and potentially other miRNAs) to the unusually long 3ЈUTR of ICOS is essential for this regulation as disruption of the miR-101 binding site disrupts the repressive activity of Roquin. However, it is still unclear whether Roquin binds to the target mRNA or to the complementary miRNA(s). It will be interesting to see whether natural sequence polymorphisms in miR-101 or in the 3ЈUTR of ICOS can be associated with autoimmune diseases.
Vascular inflammation
Inflammation is thought to contribute to multiple acute and chronic vascular diseases, including atherosclerosis, which is considered as a chronic inflammatory disease. In the formation of early lesions (fatty streaks), leucocyte activation and their infiltration to the vascular wall is an important step [93] . To date, only a few studies assessed the role of miRNAs in vascular inflammation and diseases [94] .
A recent study provided evidence that miRNAs control vascular inflammation [95] . Harris [105] . Although the mechanism of viral miRNA-mediated apoptosis inhibition seemed logical this report was recently retracted since other groups could not detect miR-LAT [106] . Interestingly, a recent study demonstrated that the assumption that LAT serves as a precursor for miRNAs was right; however, LAT-derived miRNAs seem to regulate viral genes instead of host genes (see below) [107] .
Viral miRNAs regulating viral genes
Viral miRNAs can also target viral genes and thereby interfere with host antiviral responses [108] . The polyoma virus simian (Fig. 1) . Computational analysis of the human genome suggest that the total number of miRNAs may be more than 1000 not considering other short, non-coding RNAs that were discovered only recently. Although the number of miRNA publications is increasing rapidly (Fig. 2) 
